166 related articles for article (PubMed ID: 27175077)
1. Hydrophilic mesoporous carbon nanospheres with high drug-loading efficiency for doxorubicin delivery and cancer therapy.
Wang H; Li X; Ma Z; Wang D; Wang L; Zhan J; She L; Yang F
Int J Nanomedicine; 2016; 11():1793-806. PubMed ID: 27175077
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of core-shell graphitic carbon@silica nanospheres with dual-ordered mesopores for cancer-targeted photothermochemotherapy.
Wang Y; Wang K; Zhang R; Liu X; Yan X; Wang J; Wagner E; Huang R
ACS Nano; 2014 Aug; 8(8):7870-9. PubMed ID: 25046179
[TBL] [Abstract][Full Text] [Related]
6. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
8. Folic acid-conjugated magnetic ordered mesoporous carbon nanospheres for doxorubicin targeting delivery.
Chen L; Zheng J; Du J; Yu S; Yang Y; Liu X
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109939. PubMed ID: 31500062
[TBL] [Abstract][Full Text] [Related]
9. Disulfide-cross-linked PEG-block-polypeptide nanoparticles with high drug loading content as glutathione-triggered anticancer drug nanocarriers.
Chen YF; Chang CH; Lin CY; Lin LF; Yeh ML; Jan JS
Colloids Surf B Biointerfaces; 2018 May; 165():172-181. PubMed ID: 29482128
[TBL] [Abstract][Full Text] [Related]
10. Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy.
Feng S; Ren Y; Li H; Tang Y; Yan J; Shen Z; Zhang H; Chen F
Int J Nanomedicine; 2021; 16():2123-2136. PubMed ID: 33731994
[TBL] [Abstract][Full Text] [Related]
11. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
[TBL] [Abstract][Full Text] [Related]
12. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.
Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J
Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234
[TBL] [Abstract][Full Text] [Related]
13. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
[TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticles modified hollow carbon system for dual-responsive release and chemo-photothermal synergistic therapy of tumor.
Zhao Q; Yang Y; Wang H; Lei W; Liu Y; Wang S
J Colloid Interface Sci; 2019 Oct; 554():239-249. PubMed ID: 31301524
[TBL] [Abstract][Full Text] [Related]
17. Aptavalve-gated Mesoporous Carbon Nanospheres image Cellular Mucin and provide On-demand Targeted Drug Delivery.
Li C; Qian M; Wang S; Jiang H; Du Y; Wang J; Lu W; Murthy N; Huang R
Theranostics; 2017; 7(13):3319-3325. PubMed ID: 28900512
[TBL] [Abstract][Full Text] [Related]
18. Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream.
Kang JW; Cho HJ; Lee HJ; Jin HE; Maeng HJ
Int J Biol Macromol; 2019 Mar; 125():61-71. PubMed ID: 30521919
[TBL] [Abstract][Full Text] [Related]
19. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
Wang Y; Chen X; He D; Zhou Y; Qin L
Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
[TBL] [Abstract][Full Text] [Related]
20. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
